
Two Hemophilia Drugs Lead Hematology Pipeline Update
Both drugs address an unmet need for patients with hemophilia A or B.
Patients with hemophilia and sickle cell both have unmet treatment needs, according toSandra Cuellar, a clinical associate professor and clinical oncology pharmacist at UI Health/University of Illinois at Chicago College of Pharmacy. During her Hematology/Oncology Pipeline Update presentation at the 2022 American Society of Health-System Pharmacists Summer Meetings and Exhibition,1 Cuellar dove into the drugs being researched for these conditions.
Check out our
Hematology Pipeline: Hemophilia and Sickle Cell Disease
Reference
- Cuellar S, Banks AM. Specialty pipeline updates I: hematology & oncology. Presented at: American Society of Health-System Pharmacists Summer Meetings & Exhibition; June 11-15, 2022; Phoenix, AZ
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































